{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T02:44:18Z","timestamp":1778121858046,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005076","name":"Agricultural Research Development Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017170","name":"Thailand Science Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017170","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.antiviral.2020.104927","type":"journal-article","created":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T11:08:33Z","timestamp":1599476913000},"page":"104927","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses"],"prefix":"10.1016","volume":"182","author":[{"given":"Sirin","family":"Theerawatanasirikul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4988-5124","authenticated-orcid":false,"given":"Chih Jung","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanthawan","family":"Phecharat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jullada","family":"Chootip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chalermpol","family":"Lekcharoensuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5595-3296","authenticated-orcid":false,"given":"Porntippa","family":"Lekcharoensuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2020.104927_bib1","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2165\/00003495-200565050-00005","article-title":"Amprenavir or fosamprenavir plus ritonavir in HIV infection","volume":"65","author":"Arvieux","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.antiviral.2020.104927_bib2","doi-asserted-by":"crossref","first-page":"W147","DOI":"10.1093\/nar\/gkw419","article-title":"Heatmapper: web-enabled heat mapping for all","volume":"44","author":"Babicki","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2020.104927_bib3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/vr.135.8.177","article-title":"Antiviral studies of feline infectious peritonitis virus in vitro","volume":"135","author":"Barlough","year":"1994","journal-title":"Vet. Rec."},{"key":"10.1016\/j.antiviral.2020.104927_bib4","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of covid-19 \u2014 preliminary report","author":"Beigel","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2020.104927_bib5","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/00001432-200112000-00015","article-title":"The mechanism of action of ribavirin: lethal mutagenesis of RNA virus genomes mediated by the viral RNA-dependent RNA polymerase","volume":"14","author":"Cameron","year":"2001","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104927_bib6","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2020.104927_bib7","series-title":"Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with Coronavirus Disease 2019 (COVID-19)","author":"Centers for Disease Control and Prevention","year":"2020"},{"key":"10.1016\/j.antiviral.2020.104927_bib8","series-title":"Biosafety in Microbiological and Biomedical Laboratories (BMBL)","author":"Centers for Disease Control and Prevention","year":"2009"},{"key":"10.1016\/j.antiviral.2020.104927_bib9","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1365-2125.2005.02455.x","article-title":"Population pharmacokinetics of lopinavir in combination with ritonavir in HIV-1-infected patients","volume":"60","author":"Crommentuyn","year":"2005","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.antiviral.2020.104927_bib10","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2165\/00003495-200363080-00004","article-title":"Lopinavir\/Ritonavir: a review of its use in the management of HIV infection","volume":"63","author":"Cvetkovic","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.antiviral.2020.104927_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2019.01479","article-title":"Phytophthora infestans Dihydroorotate Dehydrogenase is a potential target for chemical control \u2013 a comparison with the enzyme from solanum tuberosum","volume":"10","author":"Garavito","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.antiviral.2020.104927_bib12","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejmech.2018.03.004","article-title":"Structure-guided design of potent and permeable inhibitors of MERS coronavirus 3CL protease that utilize a piperidine moiety as a novel design element","volume":"150","author":"Galasiti Kankanamalage","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.antiviral.2020.104927_bib13","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate use of remdesivir for patients with severe Covid-19","volume":"382","author":"Grein","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2020.104927_bib14","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1128\/jcm.33.3.684-689.1995","article-title":"Detection of feline coronavirus RNA in feces, tissues, and body fluids of naturally infected cats by reverse transcriptase PCR","volume":"33","author":"Herrewegh","year":"1995","journal-title":"J. Clin. Microbiol."},{"issue":"10223","key":"10.1016\/j.antiviral.2020.104927_bib15","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan , China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2020.104927_bib16","doi-asserted-by":"crossref","first-page":"31257","DOI":"10.1074\/jbc.M502577200","article-title":"Mechanism of the maturation process of SARS-CoV 3CL protease","volume":"280","author":"Hsu","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2020.104927_bib17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2020.104927_bib18","author":"Kim"},{"key":"10.1016\/j.antiviral.2020.104927_bib19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.antiviral.2012.11.005","article-title":"Potent inhibition of feline coronaviruses with peptidyl compounds targeting coronavirus 3C-like protease","volume":"97","author":"Kim","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104927_bib20","doi-asserted-by":"crossref","first-page":"11754","DOI":"10.1128\/JVI.01348-12","article-title":"Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, noroviruses, and coronaviruses","volume":"86","author":"Kim","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104927_bib21","first-page":"862","article-title":"Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate","volume":"318","author":"Kuo","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2020.104927_bib22","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: multiple ligand-protein interaction diagrams for drug discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.antiviral.2020.104927_bib23","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.vaccine.2011.12.109","article-title":"Cloned cDNA of A\/swine\/Iowa\/15\/1930 internal genes as a candidate backbone for reverse genetics vaccine against influenza A viruses","volume":"30","author":"Lekcharoensuk","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2020.104927_bib24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.antiviral.2020.104927_bib25","first-page":"720","article-title":"Occurrence of feline coronavirus and feline infectious peritonitis virus in Thailand","volume":"43","author":"Manasateinkij","year":"2009","journal-title":"Kasetsart J.\/Nat. Sci."},{"key":"10.1016\/j.antiviral.2020.104927_bib26","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJMp2000929","article-title":"A novel coronavirus emerging in China \u2014 key questions for impact assessment","volume":"382","author":"Munster","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2020.104927_bib27","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.vetmic.2018.04.026","article-title":"The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies","volume":"219","author":"Murphy","year":"2018","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.antiviral.2020.104927_bib28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Cheminf."},{"key":"10.1016\/j.antiviral.2020.104927_bib29","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.vetmic.2018.04.026","article-title":"The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies","volume":"219","author":"Pedersen","year":"2018","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.antiviral.2020.104927_bib30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.tvjl.2014.04.016","article-title":"An update on feline infectious peritonitis: diagnostics and therapeutics","volume":"201","author":"Pedersen","year":"2014","journal-title":"Vet. J."},{"key":"10.1016\/j.antiviral.2020.104927_bib31","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1345\/aph.1Q616","article-title":"Role of raltegravir in HIV-1 management","volume":"46","author":"Rokas","year":"2012","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.antiviral.2020.104927_bib32","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41467-019-13940-6","article-title":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV","volume":"11","author":"Sheahan","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2020.104927_bib33","series-title":"Antiviral and Immunomodulatory Drugs, Canine and Feline Infectious Diseases","author":"Sykes","year":"2013"},{"key":"10.1016\/j.antiviral.2020.104927_bib34","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1039\/c0mb00298d","article-title":"The synthetic genetic interaction network reveals small molecules that target specific pathways in Saccharomyces cerevisiae w","volume":"7","author":"Tamble","year":"2011","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.antiviral.2020.104927_bib35","doi-asserted-by":"crossref","first-page":"104697","DOI":"10.1016\/j.antiviral.2019.104697","article-title":"In silico and in vitro analysis of small molecules and natural compounds targeting the 3CL protease of feline infectious peritonitis virus","volume":"174","author":"Theerawatanasirikul","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104927_bib36","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.antiviral.2020.104927_bib37","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/135965350200600401","article-title":"Combination of protease inhibitors for the treatment of HIV-1-infected patients: a review of pharmacokinetics and clinical experience","volume":"6","author":"van Heeswijk","year":"2001","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2020.104927_bib38","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1128\/JVI.02685-15","article-title":"Crystal structure of feline infectious peritonitis virus main protease in complex with synergetic dual inhibitors","volume":"90","author":"Wang","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104927_bib39","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1021\/acs.jmedchem.7b00103","article-title":"Michael acceptor-based peptidomimetic inhibitor of main protease from porcine epidemic diarrhea virus","volume":"60","author":"Wang","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2020.104927_bib40","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0378-1135(89)90049-7","article-title":"Inhibitory effects of ribavirin alone or combined with human alpha interferon on feline infectious peritonitis virus replication in vitro","volume":"20","author":"Weiss","year":"1989","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.antiviral.2020.104927_bib41","first-page":"84","article-title":"Update on antiviral therapies","volume":"7","author":"Wilkes","year":"2016","journal-title":"August\u2019s Consult. Feline Intern. Med."},{"key":"10.1016\/j.antiviral.2020.104927_bib42","series-title":"WHO Discontinues Hydroxychloroquine and Lopinavir\/ritonavir Treatment Arms for COVID-19","author":"World Health Organization","year":"2020"},{"key":"10.1016\/j.antiviral.2020.104927_bib43","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1371\/journal.pbio.0030324","article-title":"Design of wide-spectrum inhibitors targeting coronavirus main proteases","volume":"3","author":"Yang","year":"2005","journal-title":"PLoS Biol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220303417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220303417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:35:19Z","timestamp":1759062919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354220303417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":43,"alternative-id":["S0166354220303417"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104927","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104927","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104927"}}